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INTRORJJCTION 
The value of phosphatase estimation in diagnosing 
disease is derived from the f act that certain variations 
of serum phosphatase may confidently be ascribed to devia-
tions from the normal physiological state (9d ). 
Phosphomonoesterases, a subdivision of the phospha-
tases, are enzymes capable of hydrolyzing practically 
every monophosphoric ester, both aliphatic and aroma~ic, 
including a portion of the phosphoric esters of the cir-
culating . red blood cells and those present in small amounts 
in blood plasma (71). Their presence was first demon-
s trated in wheat bran and rice; at the present time, they 
have been found in practically all tissues of a variety of 
animals (19). 
Four types of phosphomonoesterases of biological sig-
nificance may be differentiated on the basis of their ac-
tivity in different pH ranges (90): 1) A type (alkaline 
phosphatase) with optimal acti vity at about pH 9.3 pre-
sent in blood plasma or serum, bone, kidney, intestine, 
mammary gland, spleen, lung, leukocytes, adrenal cortex 
and seminiferous tubules; 2) A, type (acid phosphatase) · 
with optimal activity at pH 6, occurring in mammalian 
erythrocytes and yeast; 3) A type (acid phosphatase) 
with optimal activity at pH 5, occurring in prostatic 
epithelium, spleen, kidney , blood plasma, liver, pa~ 
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creas and rice bran; 4) A. type (acid phosphatase), with-
optimal activity at about pH 3 to 4, obtained from taka dias-
t ase. 
In this investigation, we will be concerned with the 
third type, namely, the phosphatase with optimal activity 
a t pH 5. 
Some years after the discovery that phosphatases were 
hydroly~ing enzymes, it was found that these enzymes were 
capable of transferring t .he liberated phosphate to certain 
alcohols, sugars and OH-amino acids (5, 3, 73, 76). 
Considering the importance of acid phosphatase in the 
clinical dia~nosis of cancer of the prostate, and the nec-
essity for a reliable method of analysis, the present 
work is undertaken to determine whether human serum con-
tains any phosphate acceptors present in concentrations 
high enough to cause a significant change in the theoreti-
cal equimolar ratio of hydrolyzed nitrophenol to hydro-
lyzed phosphorus, when nitrophenylphosphate is the sub-
strate. 
This study is partly based on the findings of Dr. M. 
M. Davison (24), who found .a 1:1 nitrophenol to inorganic 
phosphate r~tio using a purified preparation of prostatic 
phosphatase with p-nitrophenylphosphate as substrate. 
In order to carry out this study, a simple laboratory 
method is worked out to determine both nitrophenol and in-
organic phosphate in blood serum. 
HISTORICAL REVIEW Q! LITERATURE 
Due to the fact phosphatases are widely distributed 
in the human organism and their analysis used in the diag-
nosis of many bone diseases, e.g., rickets (alkaline phos-
phatase), and in the diagnosis of cancer of the prostate 
(acid phosphatase) , the literature on the subject is vol-
uminous. 
I. Definition 
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For the purposes of this historical review, acid phos-
phatases are defined as phosphomonoesterases with optimal 
activities at pH values below 7, and in the majority of 
instances at pH values between 3.8 and 6 (82). 
Gutman (47) presented an excellent review to 1942 of 
serum acid phosphatase in patients with carcinoma of the 
prostate gland. Moog (74) reviewed the physiological sig-
nificance of the phosphomonoesterases to 1946. Finally, 
Walker and co-workers (93) made a comprehensive review of 
acid phosphatases to the present. 
II. Early Studies 1n Phosphatase 
The earliest studies of animal tissue phosphatase were 
in the alkaline pH range and those have been reviewed by 
Kay (59). A phosphatase of red blood cells with an optimum 
pH of 6.0 was demonstrated by Martland and his associates 
(71) in 1934. Acid phosphatase activity in human urine 
was first demonstrated by Demuth (25) in 1925 who found 
that human urine contained an enzyme which was capable of 
hydrolyzing hexosediPhosphate and that its optimal activity 
occurr ed at a pH of about 5 ~ 
The acid phosphata ses were not clearly demons trated 
i n animal ti ssue until 1934 when Davies (21) showed that 
phospha tases exhibiting two pH orytima were present i n 
t he liver and spleen of dogs. One of these optima was 
at pH 9.0, the other at pH 4.5 to 5.0. 
In the classi f i cation of phosphatases proposed by 
Folley and Kay (34), the phosphomonoesterases are divided 
i nto several subclasses according to source, optimal pH, 
and the effect of magnesium ion upon activity at optimal 
pH. Two classes of acid phosphomonoesterases of animal 
or igin are designated by these authors. Class A II has 
an optimal pH between 4.5 and 5.0, is not activated by 
magnesium ion, and hydrolyzes beta-glycerophosphate more 
r apidly than the alpha isomer. This enzyme had been re-
ported at that time from mammalian spleen, liver, pan-
creas, and kidney. Class A IV found in mammalian eryth-
rocytes, has an optimal pH of 6.0, is activated by mag-
nes ium ion, and hydrolyzes alpha-glycerophosphate more 
r apidly than beta-glycerophosphate. 
III. Prostatic Acid Phosphatase 
In 1935, Kutscher and Wolbergs (63) found that nor-
mal human prostate tissue and ejaculate were extremely 
rich in an acid phosphatase with a pH optimum of about 
5.0 , with no activity in the alkaline range and no acti-
vation by magnesium ions as with alkaline phosphatase. 
He also found the enz-yme was present in the testes, 
-4-
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epididymis, seminal vesicle and spermatic duct. 
Further studies in acid phosphatase by the Gutmans 
and collaborators (40,39,43,38,45,41) aroused interest 
on the subject. These authors demonstrated increased acid 
phosphatase activity at the site of osseous metastases 
fr om prostatic carcinoma (38). Later reports showed el-
evated acid phosphatase levels in serum of pati ents with 
metastasized prostatic carcinoma (39,44 , 8). This fact 
now established became the basis and aid in serum acid 
phosphatase determination for the diagnosis of prostatic 
cancer. 
It can not be assumed that the serum acid phosphatase 
is raised because the cancerous prostate produces in-
creased amounts of phosphatase, since Woodard (94) demon-
strated that the activity of this enzyme in carcinomatous 
prostatic tissue averaged somewhat less than in the normal 
or hypertrophied·gland. When prostatic cancer metasta-
sizes, invasion of lymph of blood channels is accompanied 
by escape of the prostatic secretion into the circulation 
(47, 77,95 ). Operation (88), as well as digital manipu-
lation (51) of the prostate, can cause a transient rise 
in the serum acid phosphatase. 
In 1941, Gomori (35 ) showed that acid phosphatase 
activity is localized in the glandular epithelium of the 
human prostate. The s~~e year, Huggins and Hodges (55) 
introduced androgen control in the treatment of prostate 
carcinoma, an import~nt new principle. 
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No pure crystalline preparation of prostatic acid 
phosphatase has been reported. Partial purification has 
been a ccomplished by a combination of methods: electro-
dialysis, adsorption on alumina, elution with citrate and 
ammonium sul·fate fractionation (65). This procedure re-
sulted in 100-120 fold concentration. Others have reported 
preparations by ammonium sulfate precipitation(27),and 
also ethanol precipitation (54,23). 
I V. Substrate Specificity 
The problem of whether there are different kinds of 
phosphatases in different tissues ,, or even within the 
same cell, has attracted wide interest. If there are dif-
ferent phosphatases, they should have different substrate 
specificities as well as different pH optima and different 
responses to the presence of activators and inhibi tors. 
Many substrates have been used for acid phosphatase; among 
the most important are:a)phosphorylated aliphatic and aro-
matic alcohols used by Hotta (52) who found that aliphatic 
alcohols were hydrolyzed more rapidly than aromatic. Hotta 
also used pyrophosphates and N-phosphorylated compounds 
and concluded that different phosphatases were specific as 
phosphomonoesterases, pyrophosphatases, or phosphamidases; 
b) Alpha- and beta-glycerophosphates were used as sub-
strates by Ha shimoto (49); c) Aminoethanol monophosphate , 
dimethyl aminoethanol monophosphate, choline phosphate, 
glucose-1-phosphate, benzyl phosphate, and beta-glycerophos-
pha te were used by Fleury and associates (33) . 
Their conclusion could be summarized by saying, that al-
though phosphatases from various sources could be grouped 
according to pH optimum and inhibitor effects, they were 
all broad in their action and overlapped in their ef-
fects on various substrates; d) Scott and Huggins (85) 
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used phenyl phosphate as did Reis (81); e) Lundquist (68) 
compared the action of prostatic phosphatase on the follow-
i ng substrates: phosphorylcholine, beta-glycerophosphate , 
and phenyl phosphate; f) Hudson and Butler (54) used as 
substrates, adenosine triphosphate, glucose-1-phosphate, 
glucose-6-phosphate, hexose diphosphate, and fructose-6-
phosphate. Semen and purified prostatic phosphatase acted 
similarly although there were differences in pH optima a-
mong the various substrates. g) Finally, the following 
substrates have been used: Sodium phenolphthalein phos-
phate (57) , creatine phosphate (76), and p-nitrophenyl-
phosphate introduced by Ohmori (80) and widely used at 
the present (5,14,24). 
From the evidence briefly mentioned above, it can 
be said that 11 acid phosphatase", is not a single enzyme 
but a group of enzymes including enzymes of different 
substrate specifi city, unified only by their character-
istic catalytic effect, exerted in an acid environment, 
upon the hydrolysis of phosphoric monoesters (93). 
v. Activators and Inhibitors 
.;;.;;..;;;..-.;;;;........-.-.-. ........ -
Magnesium i£n activated many alkaline phosphatases, 
but was without effect upon the acid phosphatase of pros-
tate {64) . Fluoride, oxalate and trichloroacetat e in-
hibited acid phosphatase s of liver and kidney (10). O.OlM 
sodium fluoride caused 82.6 percent inhibition of pros-
tatic acid phosphatase when glycerophosphate was the sub-
strate (64). 
Abul-Fadl and King (1) showed the following: For-
......... 
maldehyde had no effect on prostatic phospha tases but in-
hibited completely the action of red cell phosphatase. 
1-tartrate completely inhibited prostatic or liver acid 
phosphatase but had no effect on the erythrocyte enzyme 
or on the acid phosphatase of bile. :M_a_l_e_i_c ~ radical 
activat ed the red blood cell and prostatic phosphatases 
slightly. Lactic, oyruvic,malic, malonic, mucic , fumaric , 
~uccinic, and tartronic ~radicals were wi thout effect. 
Red cell acid phosphatases are notably inhibited by cup-
£1£ ~' whereas the prostatic enzyme was slightly ac-
tivated by O.OOlM copper sulfate. 
Prostatic acid phosphat ase was inactivated by certain 
alcohols and urethane (64). The question of alcohol inhi-
bition is complicated by the phenomenon of transphosphoryl-
ation (3 ) . Oxidants and reductants were investigated by 
Sizer (87) who found that all reductants and mild oxidant s 
were without effect , but that phosphatase activity was 
gr eatly decreased by the addition of strong oxidants. 
Phlorizin inhibition was studied by Beck (9) who 
found that the kidney enzyme was markedly inhibited by 
phlorizin regardless of substrate. Bossard (16) found 
that molybdate 1Qg strongly inhibited all phosphatases. 
Nitrous~' formaldehyde, and phenY:lisocyanate, all 
inhibited acid phosphatase activity according to Baccari 
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and Auricchio (7). Mattocks and Holtan (72) investigated 
various inhibiting substances on the acid phosphatase of 
sheep brain. They found that the phosphatase was inhi-
bited competitively by sulfate, pyrophosphate, and diisooro-
pylfluorophosphate. Fluoride inhibited the enzyme in a 
non-competitive manner. Cyanide, iodoacetate, alanine, 
glutathione, ascorbic ~' acetylcholine, carbamylcholine, 
choline, urethane, tetraethylpyrophosphate, myanesin, cysteine, 
glutamic ~, para-aminoben~oic ~' creatine, cystine, 
procaine, sulfanilamide, and piloc~rgine had no effect 
on the enzyme. 
VI. Mechanism Qf Reaction 
Cohn (20) showed that the places where phosphoric 
acid esters were split differed in acid hydrolysis and 
acid enzyme hydrolysis. According to Cohn, the acid hydro-
lysis of a phosphoric acid ester proceeded in the follow-
ing manner: 
OH OH 
I I I 
HO- Pt ... Lo-R~ HQ-pl-+l.o+ R 
I I I 
0 OH 
OH 
f --~>- HQ-P(•J-o(-) + R l-t-) 
I 
OH 
Acid Catalyzed 
--+llo ROH + H(i") 
The enzymi c mechani sm was shown to pr oceed in a 
s l i ghtly differ ent manner wi th the splitting of the P-0 
bond rather than of the 0- R bond: 
OH OH 
I I 
HO-P(t)_O-R + H<~ Ho-p <tL oR 
OH 
1-
HO-P1tLoR + 
I 
OH 
I I 
OH OH 
OH OH 
I I H20~ 0H-Pl+loR~ Ho-p<.,.L oH + 
I I 
OH OH 
VII. Transphosphorylation React ions 
Hl+) + ROH 
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Appleyard (3) basing her work on the findings of 
Axelrod (5) demonstrated that a partially purified ex-
tract of human prostate catalyzed the transfer of phosphate 
between pentasodiumphenolphthaleindiphosphate and certain 
aliphatic alcb.hols. The presence of these alcohols in-
creased the liberation of free phenolphthalein without 
app.:reciably affecting the formation of free phosphate . 
Appleyard's assumption was that two enzymes were ~ nvolved, 
a phosphatase and a transphosphorylase, and that the lat-
ter competed for t he phenophtbalein more effectively 
t han did the phosphatase. Transphosphorylases or phospho-
transferases are enzymes capable of phosphate transfer 
without participation of ATP . Axelrod reported that .kid-
ney alkaline phosphatase was inactive as a transferase. 
Aryl phosphates were good donors; aliphatic alcoho~s were 
satisfactory. acceptors. The ratio of phos-phate transferred 
to substrate cleaved increased within limits wi ·t h decreas-
ing pH; it was independent of donor concentration but 
increases with acceptor concentration. By using labeled 
P, Axelrod (6) was able to show that the phosphate trans-
ferred did not pass through the state of free phosphate 
ion. 
Transphosphorylation to biologic alcohols from or-
ganic phosphate donors occured in the presence of pros-
tatic (3) or seminal fluid phosphatase (37) This direct 
transfer of phosphate groups seemed to require that the 
phosphate donor and acceptor react simultaneously with the 
same enzyme molecule. 
Brawerman and Chargaff (18) showed that prostatic 
acid phosphatase catalyzed the transfer ig vitro of 
phosphate ion from phenylphosphate to ribose nucleosides 
and desoxyribonucleosides, synthesizing the corresponding 
nucleotides. 
Morton (76) used highly purified alkaline phospha-
tase, partially purified prostatic phosphatase, kidney 
hexose diphosphatase, 5-nucleotidase from bull testes, 
and muscle myosin-adenosine t riphosphatase to study trans-
-
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ferase activity. His results showed that certain compounds, 
containing hydroxyl groups can successfully comp~t. e wi ~h 
water for a site at the enzyme surfaces of the alkaline 
a nd acid phosphatases , but not a t those of the substrate-
specifi c phosphatases. The group-specific acid and alka-
line phosphat ases clearly have a measurable affinity for 
acceptors , such as glucose and glycerol as well as water, 
and the author suggested that the enzymes which show 
-12-
strict specificity toward the donor also show strict 
specificity toward water a s the phosphate acceptor. The 
author concluded that there seems no good reason for at-
tributing any longer the transferase activity to enzymes 
associated with, but distinct from, the hydrolases. Note 
that this work disproves the conclusions reached by Apple-
yard (3). 
VIII. Physiologic Functions Qf ~ Bhosphatase 
Very little is known about the physiological im-
portance of prostatic acid phosphatase. Lundquist (68) 
suggested that the splitting of phosphoryl choline, pre-
sent in human semen, is the sole function of prostatic 
phosphatase. 
Drabkin (28) proved that the phosphatases of the kid-
ney are concentrated in the cells of the proximal con-
voluted tubules, which is the chief site of glucose reab-
sorptions. 
Phosphatases are important in mucopolysaccharide 
formation, since they liberate from hexosephospbate the 
necessary sugars in a nascent state and at the site. The 
hexosepbosphates were assumed to originate by the phos-
phorylytic degradation of glycogen (62). 
Finally, Norberg (79) showed that liver regeneration 
in the rat was accompanied by a large increase in the 
several acid phosphatases present. This suggested a re-
lation between these enzymes and protein synthesis. 
EXPERIMENTAL 
I. DEVELOPl!ENT .Q! ME THOD 
Since a method was essential to determine both 
nitrophenol and inorganic phosphate in the presence of 
serum -at. present nonexistent in the literature- first 
efforts were directed toward this goal. 
a) Determination£! nitronhenol 
For the determination of nitrophenol, a method 
was found, used previously by Andersch and Szczypin-
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sky (2). They used as substrate disodium p-nitrophenyl-
phosphate, but their paper·, made no mention of its pur-
ity. Therefore, Sigma disodium p-nitrophenylphosphate 
was analyzed by Dr . Carol Fitz and found to have the 
fol lowing composition: C = 19%, H =- 4. 3%, N = 3. 5%, 
*P-= 8. 4% and ash= 36. 8%. From this data a formula of 
Naz - N02¢Po4 .6Hz0 was assumed. 
The concentration for the substrate was changed 
from 1.33 mg/ml - used by Andersch and Szczypinski, to 
that of 0.98 mg/ml used by Davison and co-workers (24). 
The reason for this change was based on the fact the 
first substrate concentration gave too high a blank. 
This substrate concentration was diluted in pH 5.0 ace-
tate buffer, ionic strength 0.2. 
An absorption spectra was next done of nitrophenol 
and the substrate, to determine the wave length a t 
which maximum absorption occurs . . The results follow: 
*Analysis of P done by Dr. Moi ra M. Davison. 
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A - Blank - - - = acetate buffer pH 5. 0 ,_.M=O. 2 
B- Nitrophenol= acetate buffer plus 1.0 ~ nitrophenol 
C- Substrate -= .93 mg/ml in pH 5.0 acetate buffer 
~length 
385 - --- ---
390 
- -
395 - - - -
400 
- - - -
405 
- -
406 
- -
410 
- - -
-
420 
- - - -
430 - - - -
435 
- -
h. 
0 -
0 
0 - -
0 - - - -
0-
0 - - - -
0-
0 - - - -
0 - - - -
0 - - - -
B c 
-
-.063 - - - - - - ---
~-107 - - - - - - ---
- -.141- - - - ---
- -.I67 - - - - - - ---
-.172 - - - - - - ~05 
- -.171- - - - ~01 
-.167 - - - - ---
- - . 142 - - - - - - ---
- -.103 - - - - ---
- -.065- - - - ---
-see graph in the appendix 
As noted in the previous data, maximum absorption 
occured at 405 ~for nitrophenol, being practically 
negligible for the substrate. For this reason, the 
400 ~ filter was used instead of the 420 m)t, the for-
mer being closer to the point where maximum absorption 
occurs. 
Enzymic activity was determined as follows: 1 ml 
of pooled serwn was added to 5 ml of substrate and in-
cubated 38°0 for one hour. At the end of the incuba-
tion time, the tube was placed in ice -water for approxim-
ately five minutes. One ml was then added to an Evelyn 
tube containing 9 ml of 0.1 N sodium hydroxlde, shaken 
and allowed to stand for 10 minutes, then read at 400 ~ 
in the Evelyn colorimeter against a blaruc. To correct 
for the serum color, one ml of unincubated sample was 
added to 9 ml of 0.1 N sodiwn hydroxide and used as a 
blank. 
This method differs from that of Andersch 
and Szczypinski (2). These workers used only half an 
hour incubation period, read their samples at 420 ~ 
and used 2 ml of hydrolysate and 8 ml of 0.1 N sodium 
hydroxide. 
The hydrolysis of serum is proportional to the 
time of incubation, up to three hours (2). 
b) Determination .Q! inorganic phosphate 
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A modification of the Lowry and Lopez method for 
labile phosphate esters (6'7) was used. To the remain-
ing ice cold mixture, 5 ml of lo% trichloroacetic acid 
(TCA) were added (final TCA concentration 5%) to pre-
cipitate the serwn protein. The precipitate wa s cen-
trifuged in the cold (5°0) for ten minutes at 2500 rfc -
gravities·To 5 ml of acetate buffer pH 4.0 ionic strength 
0.4 in an Evelyn tube, 4 ml of the supernatant hydro-
lysate were added. To develop the color, 1 ml of 1% 
ammonium molybdate in 0.05 N sulfuric acid and 1 ml of 
0.25% ascorbic acid (made immediately preceding its ad-
dition), were added. The mixture was allowed to stand 
for 15 minutes and read at 720 ~ in the Evelyn color-
imeter against a reagent blank. 
To avoid the hydrolysis of labile phosphate, ice 
cold trichloroacetic acid is essential, as is keeping 
the pH at 4.0 in the presence of the molybdate solution 
(67). Further, it was learned that speed in the addition 
of solutions increases the accuracy of the determination. 
Serwn inorganic phosphate was determined in a 
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similar manner using an unincubated srunple. Thus the 
free phosphate present as a result of enzyme activity was 
measured by subtracting the unincubated from the i ncub-
ated value. 
c) The precipitation Q! protein from serun1 
The elimination of protein previous to the determ-
ination of inorganic phosphate presented a problem. Sev-
eral concentrations of trichloroacetic acid were used. 
The results follow: 
Digest plus 5% TCA - 34 35 - cloudy 
Digest plus 1~ TCA - 36 36 - clear 
Digest plus 15% TCA - 36 36 - clear 
As noted from the data above, 5% TOA did not elim-
inate all the protein in serum, while the lo% and the 
15% concentrations did. The 10% concentration was a-
. dopted for this method because it solved the problem 
without overcharging: ~he digest with TCA. Moreover, it 
was essential to maintain a pH of 4.0 when the digest 
was added to the buffer during color development. This 
did not happen when 1~ TOA was used. Determinations 
(glass electrode) showed the · following results: 
Digest plus ~ TOA - pH 4.0 
Digest plus l()J~ TOA - pH 4. 0 
Digest plus 15% TCA- pH 3.0 
In order to buffer the amount of acid added, the 
ionic strength was increas~d to 0.4. 
II. ~PR~o_o_F~S 1li!! ~ANALYTICAL METHOD 1£ SATISFACTORY 
a) Proof 1!llt.l !h.£ method devised give,s ill hydrolysis 
!'a1i.Q .Qf. u.,i.troph~,gli£ inorganic nhosphate 
Davison and co-workers (24) found that prostatic 
acid phosphatase hydrolysed equimolar quantities of 
nitrophenol and inorganic phosphate (using p-nitro-
phenylphosphate as substrate); nevertheless they were 
not concerned with the presence of protein which implies 
its elimination through precipitation with acid. There-
fore. an experiment was carried out to show that the 
same 1:1 ratio is present when protein is in the solu-
tion. 
To do this, 7% bovine albumin (protein concentra-
tion approximating that of human serum) was used; and 
the prostatic acid phosphatase purified by Davison (23) 
was diluted in the albumin. The method used was the 
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one worked out in this paper. The results were as follows: 
mM nitrophenol 
hydrolyzed 
0.67 
mM. inorgani,c phosphaE 
hydrol:rz,ed 
0.67 
These results show that the necessary elimination 
of protein did not alter the 1:1 ratio. 
b) Proof~ ratio changes !a presence £f ·~suitable 
accentor 2f ~ppropriate concentration 
As a suitable acceptor, propylene glycol was adopt-
ed and the following experiment performed: to the sub-
strate and diluted enzyme mixture, 0.5ml propylene 
glycol was added. As a control water was substituted 
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for propylene glycol in another set of tubes. The re-
sults follow: 
mM !!!}! 
ni t1oj?ii'enol inorganic nhosphate 
A - (with water) -
B (with propylene glycol) .63 . -.so .59 • 31 
Note that an increase in nitrophenol hydrolyzed occurs 
when propylene glycol is present (24), whil e a consider-
able decrease in inorganic phosphate is evident, prov-
ing pr opylene glycol worked a s an acceptor. 
During the actual experiment, whole blood was drawn 
by intravenous puncture (approximately 15 ml ); this, after 
clotting was centrifuged as soon as possible, and the 
serum drawn into a separate tube. The serum can be kept 
in the frozen state with the prostatic acid phosphat ase 
a ctivity remaining unchanged almost indefinitely (22), 
while at room temperature it declines rapidly (95). 
III . NITROPHENOL ~ INORGANIC PHOSPHATE STANDARD CURVES 
These curves were made using the method adopted, 
and stock solutions of nitr ophenol and potassium acid 
phosphate. 
~see appendix for graphs. 
IV. THE ANALYSES OF NORMAL AND PATHOLOGICAL SERA 
__..,... - -.-. ~
Two sets of sera were analyzed, those assumed normal, 
taken from laboratory personnel at the Boston University 
School of Medicine; and pathological cases, obtained 
from patients a t Massachusetts Memorial Hospitals and 
the Boston City Hospital. The s e last ones (pathological 
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cases), were assured of a definite diagnosis by competent 
staff physicians of said institutions. The age and sex 
in each case is reported. In sera No. 2, the analysis 
was repeated due to its high elevation the first time 
it was analyzed, in both analyses the results are con-
sistent and reliable. 
Throughout the experiment all determinations were 
done in duplicate, with a precision of :t0.5% Transmit-
tance. 
The results follow on the next page. 
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NORMAL CASES 
Case 
Control Determination 
No . Age Sex Noa¢A...Po~ · 'i.oa.O ~P.o 4' Ratio differe~ 
- -
1 26 M 0.64 0.64 0.39 0.37 +0.05 
2 32 M 0.64 0.62 0.63 0.62 -0.01 
*0.63 0.61 0.51 0.52 -0.05 
3 27 M 0.68 0.68 0.36 0.31 +0.16 
4 30 M 0.64 0.62 0.36 0.37 -0.05 
5 38 M 0.57 0.55 0.38 0.34 +0.08 
6 25 M 0.57 0.55 0.45 0.43 +0.01 
7 25 M 0.68 0.65 0.54 0.48 +0.08 
8 22 M 0.68 0.65 0.54 0.51 +0.02 
9 30 F 0.64 0.62 0.28 0.27 +0.01 
10 25 F 0.63 0.62 0.33 0.34 -0.04 
11 22 F 0.64 0.64 0.36 0.40 -0.10 
12 33 F 0.64 0.64 0.39 0.35 +0.11 
13 38 F 0.64 0.62 0.36 0.30 +0.17 
14 42 F 0,63 0.62 0.41 0.36 +0.13 
15 24 F 0.62 0.58 0.40 0.33 +0.14 
16 48 F 0.63 0.59 0.34 0.34 -0.07 
*Repea ted case 
PATHOLOGICAL CASES 
Control Determina tion 
-~ ~Ratio !2.:... Age ~ Diagnosis N02,& . !:04 diff. 
1 53 M Diabetes 0~62 0.60 0.55 0.51 +0.09 
2 70 M Peptic Ulcer 0.65 0.65 0.57 0.53 +0.07 
3 57 M Carcinomatosis 0.61 0.58 0.74 0.76 -0.07 
4 63 M Cirrhosis 0.65 0.65 0.66 0.68 -0.02 
5 57 M Calcif. Scar 0.65 ·o. 65 0.54 0.48 +0.12 
6 70 M Metastatic Ca. 0.65 0.65 0.69 0.63 +0.10 
7 43 M Peptic Ulcer 0.65 0.65 0.55 0.53 +0.06 
8 54 M Duod. Ulcer 0.63 0.61 0.74 0.74 -0.03 
9 55 M Pancreatitis 0.63 0.61 0.46 0.48 -0.07 
10 53 M Ca. Rectum 0.63 0.61 0.63 0.60 +0. 02 
11 77 F Ca. Breast 0.63 0.59 0.93 1.00 -0.14 
l2 75 F Diabetes 0.65 0.65 0.60 0.60 o.oo 
13 77 F Diabetes 0.61 0.58 0.58 0.60 -0.08 
e 14 49 F Diabetes 0.61 0.58 0.50 0.54 -0.12 15 29 F Nephritis 0.61 0.58 0.51 0.45 +0.06 
16 56 F Pyelonephritis 0.63 0.61 0.61 0.64 -0.08 
The analyses covered a p eriod of five weeks, and as 
shown above, a number of 16 normals and 16 pathological 
cases were studied and analyzed. 
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DISCUSSION ~ CONCLUSIONS 
As noted in the data given, the millimol of nitro-
phenol hydrolyzed from serum, ranged in the normal cases 
from 0.28 to 0.63. The se figures are consistent with 
Andersch and Szczypinski's conclusions (2) who found 
the normals to be from 0.01 to 0.63 mM/L. If broken 
down, the serum of 8 women ranged from 0.28 ,to 0.41 mil-
limol units with an average of 0.36 units . The range 
for 8 men was from 0.36 to 0.63 millimol units with an 
average of 0.46 units. 
In regard to the pathological cases, a mde variety 
of cases were analyzed; in all, an elevated acid phospha-
tase was evident, the range being 0.46 millimol units on 
a patient with pancreatitis to 0.93 millimol units on 
a patient with untrea ted carcinoma of the breast. The 
overall average was 0.62 units. 
High acid phosphatase activity was found in the 
patients with cancer. This is in accord with the work 
of Lemon and co-workers (66). 
As seen in the recopila tion of cases, a column en-
titled, 11B.atio Difference~• is meant to show if in the par-
ticular case an acceptor (+) is found or an increase in 
inorganic phosphate is evident (-) over the nitrophenol. 
These values were arrived at by taking the ratio of nitro-
phenol to inorganic phosphate and subtracting this value 
from the control run in each analyses. (The control was 
run with prostatic acid phosphatase and 7% albllinin). 
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EXAMPLE: (Case No.1); ni trophenol hydrolyzed= 0. 39 mM 
inorganic phos ;>hate = 0. 37 mM: , r a tio= 1.05. This r atio 
minus the ratio of the cont:rol run, which, in this case, 
was 1.0, equals :ratio difference of + 0.05, that is, an 
inorganic phosphate acceptor is evident. Throughout 
the \rork (including normals and pathological ca ses), 
only small differences were found. 
This study was prompted in part by the fact that 
Nesbitt and Baum (77) found that 35% (from 1150 cases 
studied), of cases with recognized extension of their 
neoplasm to lymph nodes or bone, had a normal serurn 
titre of acid phosphatase on first examination. This 
fact suggested the possibility of an acceptor(s) present 
in serum that could lower, under certain conditions, 
the values obtained. The present work seems to rule 
out such possibility. This is an interesting finding 
in view of the fact that Brand and co-workers (17a) 
showed that bovine albumin contains significant quan-
tities of hydroxyamino acids, and these are potential 
phospha te acceptors: 
Serine 
Threonine 
Tyrosine 
Finally, it can be said, that the results obtained 
are negative, with the substrate used, that is, no ac-
ceptor(s) seem(s) to be present in proper concentration. 
The method devised and presented appea.rs adequate, ac-
curate and simple for clinical use. 
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